Publications by authors named "Mario Scuri"

Claim this Profile
V
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.
Judith Garcia-Aymerich, Milo A Puhan, Solange Corriol-Rohou, Corina de Jong, Heleen Demeyer, Mario Scuri

Thorax· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
Alfredo Chetta, Arzu Yorgancioglu, Mario Scuri, Sara Barile, Daniele Guastalla

BMC Pulm Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled corticosteroid containing combinations and mortality in COPD.
Jørgen Vestbo, Leonardo Fabbri, Alberto Papi, Stefano Petruzzelli, Mario Scuri

Eur Respir J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
Dave Singh, Massimo Corradi, Monica Spinola, Alberto Papi, Omar S Usmani, Mario Scuri

Int J Chron Obstruct Pulmon Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study.
Dave Singh, Mario Scuri, Sara Collarini, Stefano Vezzoli, Fabrizia Mariotti

Int J Chron Obstruct Pulmon Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Alberto Papi, Jørgen Vestbo, Leonardo Fabbri, Massimo Corradi, Hélène Prunier, Mario Scuri

Lancet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Mario Scuri

Lancet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study.
Dave Singh, Giorgia Ciurlia, Annalisa Piccinno, Annamaria Muraro, Maria Bocchi, Mario Scuri

Pulm Pharmacol Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
Ernesto Crisafulli, Andrea Zanini, Giovanna Pisi, Patrizia Pignatti, Gianluigi Poli, Mario Scuri

Expert Rev Respir Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
Pierluigi Paggiaro, Massimo Corradi, Manuela Latorre, Helene Raptis, Annamaria Muraro, Mario Scuri

BMC Pulm Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Mario Scuri

Lancet· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
Piotr Kuna, Mirco Govoni, Germano Lucci, Mario Scuri, Daniela Acerbi

Br J Clin Pharmacol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
Frank Kanniess, Mario Scuri, Stefano Vezzoli, Catherine Francisco, Stefano Petruzzelli

Pulm Pharmacol Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.
Thomas Voshaar, Monica Spinola, Patrick Linnane, Alice Campanini, Daniel Lock, Mario Scuri

J Aerosol Med Pulm Drug Deliv· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotrophic and neuroimmune responses to early-life Pseudomonas aeruginosa infection in rat lungs.
Silvia Cardenas, Mario Scuri, Lennie Samsell, Barbara Ducatman, Pablo Bejarano

Am J Physiol Lung Cell Mol Physiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways.
Mario Scuri, Bean T Chen, Vincent Castranova, Jeffrey S Reynolds, Victor J Johnson

J Toxicol Environ Health A· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of neurotrophins in inflammation and allergy.
Mario Scuri, Lennie Samsell, Giovanni Piedimonte

Inflamm Allergy Drug Targets· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung.
Fernando Urrego, Mario Scuri, Alexander Auais, Lida Mohtasham, Giovanni Piedimonte

Pediatr Pulmonol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep.
Mario Scuri, Juan R Sabater, William M Abraham

J Appl Physiol (1985)· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure.
Michele Senni, Giovanna Santilli, Piervirgilio Parrella, Renata De Maria, Gabriella Alari, Mario Scuri

Am J Cardiol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
William M Abraham, Mario Scuri, Stephen G Farmer

Eur J Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan blocks human neutrophil elastase (HNE)-induced airway responses in sheep.
Mario Scuri, William M Abraham

Pulm Pharmacol Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep.
Mario Scuri, Yelena Botvinnikova, Isabel T Lauredo, William M Abraham

J Appl Physiol (1985)· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis